• Epygen plans to raise Rs 300 cr to propel biosimilars in India

    • May 11, 2018
    • Posted By : admin
    • 0 Comment

    Epygen Biotech today said it plans to raise Rs 300 crore in the next three years to fuel launch of its exciting biosimilar pipeline.
    The funding will provide Epygen with the best possible conditions to propel clinical trial programs of its pipeline molecules in the field of oncology and cardiology, which are showing substantial promise in protein expression and purification, the company said in a release.
    Yes Bank partners with NSFI for training 10,000 farmers *Private sector lender Yes Bank today said it has partnered with National Skills Foundation of India (NSFI) for training 10,000 farmers on digital literacy, financial inclusion and good agri practices.
    A bank statement said first phase of the programme has been launched in 15 districts of Rajasthan and Haryana.
    HSBC introduces transactions via facial recognition *British banking major HSBC today said its corporate clients in the country can transact using a newly-launched facial recognition feature.
    The country is among 24 markets globally where the feature has been introduced to speed up the log-in process and increase account security, an official statement said.
    India Transact Services launches new PoS solution *AGS Transact Technologies arm India Transact Services today said it has launched a point of sale (PoS) device which can complete transactions using multiple payment modes.
    End-consumers can make payments using QR codes, mobile wallets, BHIM-UPI and also merchant sponsored closed-loop prepaid card swipe in addition to the regular credit and debit card transactions, an official statement said.


You Might Also Like

No comments found



error: Content is protected !!